Overview Types of Narcolepsy Epidemiology Causes Symptoms Pathophysiology Diagnosis Treatment Pipeline Therapeutics Competitive Landscape Comparative Analysis Late Stage Products (Phase III) Comparative Analysis Solriamfetol: Jazz Pharmaceuticals Product Description Research and Development Product Development Activities (The list continues) Mid Stage Products (Phase II) Comparative Analysis Early Stage Products (Phase I and IND) Comparative Analysis Pre-clinical and Discovery Products Comparative Analysis Therapeutic Assessment Assessment by Product Type Assessment by Route of Administration Assessment by Stage and Route of Administration Dormant and Discontinued Products Comparative Analysis Appendix

Table 1: Total Products for Narcolepsy Table 2: Late Stage Products (Phase III) Table 3: Mid Stage Products (Phase II) Table 4: Early Stage Products (Phase I and IND) Table 5: Pre-clinical and Discovery Stage Products Table 6: Assessment by Mono Products Table 7: Assessment by Combination Products Table 8: Assessment by Route of Administration Table 9: Assessment by Stage and Route of Administration Table 10: Dormant Products Table 11: Discontinued Products Figure 1: Pathophysiology of Narcolepsy Figure 2: Total Products for Narcolepsy Figure 3: Late Stage Products (Phase III) Figure 4: Mid Stage Products (Phase II) Figure 5: Early Stage Products (Phase I and IND) Figure 6: Pre-clinical and Discovery Stage Products Figure 7: Assessment by Product Type Figure 8: Assessment by Route of Administration Figure 9: Assessment by Stage and Route of Administration Figure 10: Dormant and Discontinued Products

Arena Pharmaceuticals Avadel Pharmaceuticals Balance Therapeutics Evotec AG GlaxoSmithKline Heptares Therapeutics Jazz Pharmaceuticals Johnson & Johnson NLS Pharma Ono Pharmaceutical OptiNose Pfizer Reset Therapeutics Roche Sanofi Seelos Therapeutics Taisho Pharmaceutical Takeda Theranexus